UNIGE document Scientific Article
previous document  unige:33652  next document
add to browser collection


Published in Revue médicale suisse. 2013, vol. 9, no. 369, p. 125-31
Abstract Type 2 diadetes is associated with an increased risk of fractures. Calcium supplements are still in the middle of a cardiovascular controversy. Swiss recommandations are available for vitamin D supplementation. Zoledronate exerts a long-term remaining effect on bone resorption. After 5 years treatment with denosumab, fracture incidence remains low. Atypical femoral fractures associated with bisphosphonates treatment have been evaluated in the university hospital of Geneva.
Keywords Bone Density Conservation Agents/therapeutic useCalcium, Dietary/administration & dosageDiabetes Mellitus, Type 2/complicationsDiphosphonates/therapeutic useHumansNutritional RequirementsOsteoporosis/etiology/prevention & controlOsteoporotic Fractures/prevention & controlVitamin D/therapeutic use
PMID: 23409650
Full text
Article (Published version) (800 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://rms.medhyg.ch/numero-369-page-125.htm
Research group Nutrition et os (66)
(ISO format)
UEBELHART, Brigitte Florence, RIZZOLI, René. Ostéoporose. In: Revue médicale suisse, 2013, vol. 9, n° 369, p. 125-31. https://archive-ouverte.unige.ch/unige:33652

342 hits

1 download


Deposited on : 2014-01-24

Export document
Format :
Citation style :